Vigonvita Life Sciences Co., Ltd.
Vigonvita Life Sciences Co., Ltd. (HKSE: 2630) is trading at HK$80.00, about ₹979 at today's HKD/INR rate, as of 30 Sep 2026, 3:23 AM ET, up 2.56% today. Indian residents can buy Vigonvita Life Sciences from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
HK$79.00
Today's high
HK$81.00
52 week low
HK$51.00
52 week high
HK$134.90
2630 opened at HK$79.00, closed previously at HK$78.00, and has traded between HK$51.00 and HK$134.90 over the past 52 weeks.
About
Vigonvita Life Sciences Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule drugs for neuropsychiatry, reproductive health, and viral infection therapeutic areas. Its products include LV232, a first-in-class dual-target 5-HTT/5-HT modulators, which is in Phase II of clinical trial for the treatment of depressive disorder; and TPN171, a type-5 phosphodiesterase inhibitor completed Phase III clinical trial for the treatment of erectile dysfunction. The company also develops VV116, a RNA-dependent RNA polymerase inhibitor completed a Phase II clinical trial for the treatment of respiratory syncytial virus infection, as well as COVID-19 infections; TPN102, a novel antiepileptic drug, which is in Phase I clinical trial for the treatment of epilepsy; VV119, a multi-target serotonin-dopamine activity modulator, which is in Phase I clinical trial for the treatment of psychiatric disorders and schizophrenia; VV261, a novel nucleoside prodrug, which is in Phase I clinical trial for chikungunya, coronaviruses, influenza, and arena virus. In addition, it develops VV913, a novel investigational drug candidate for premature ejaculation; VV147 for the treatment of major depressive disorder; and VV207 for the treatment of adenovirus infection. The company was incorporated in 2013 and is headquartered in Suzhou, China.
Key statistics
Avg. volume
82.06K
Market cap
HK$13.35B
P/E Ratio
—
Price-to-sales ratio
—
Enterprise value
—
Free cash flow yield
—
Debt-to-equity ratio
—
Return on equity
—
ROIC
—
Beta
2.70
Dividend yield
—
Last dividend
HK$0.00
Financial overview
Revenue
—
Earnings per share
—
Free cash flow
—
Net profit margin
—
Gross margin
—
EBITDA
—
Revenue growth
—
How to buy Vigonvita Life Sciences from India
Indian residents can buy Vigonvita Life Sciences shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to HKD.
Search for Vigonvita Life Sciences and place an order
Find Vigonvita Life Sciences by name or by its ticker, 2630, and choose an order type. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. Vigonvita Life Sciences trades 7:00 am – 1:30 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Vigonvita Life Sciences position in HKD and INR. Vigonvita Life Sciences pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in Vigonvita Life Sciences from India
Trading and taxes when buying Vigonvita Life Sciences from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm HKT
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneVigonvita Life Sciences does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy Vigonvita Life Sciences stock?
Yes. Vigonvita Life Sciences (2630) has been listed on the Hong Kong Stock Exchange since 2025, in the Drug Manufacturers - General industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to HKD. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one Vigonvita Life Sciences share cost in rupees?
One Vigonvita Life Sciences share is HK$80.00 — about ₹979 at an HKD/INR rate of 12.24 on 29 Sep 2026. Both the Vigonvita Life Sciences price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Vigonvita Life Sciences from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
What is the minimum I can buy of Vigonvita Life Sciences?
Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.
How are gains on Vigonvita Life Sciences shares taxed in India?
Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the HKD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Vigonvita Life Sciences price. Paasa issues a capital-gains statement for your return.
Does Vigonvita Life Sciences pay a dividend?
No. Vigonvita Life Sciences does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade Vigonvita Life Sciences from India?
The Hong Kong Stock Exchange trades 7:00 am – 1:30 pm IST in Indian time. It also halts for lunch, 9:30 am – 10:30 am IST. Orders can only execute during that window.
Is Vigonvita Life Sciences a Hong Kong SAR China company, and does that change how it is taxed?
Vigonvita Life Sciences trades on the Hong Kong Stock Exchange in HKD, but the company is domiciled in China. Vigonvita Life Sciences trades as an ordinary share listed directly in Hong Kong, not a depositary receipt. Your India-side capital-gains treatment is the same either way.
Do I have to declare Vigonvita Life Sciences shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Vigonvita Life Sciences holding, its cost and its closing value.
How do I sell Vigonvita Life Sciences and bring the money back to India?
You sell during market hours (7:00 am – 1:30 pm IST) and the proceeds settle in HKD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.